Five critical elements to ensure the precision medicine

被引:36
作者
Chen, Chengshui [1 ]
He, Mingyan [2 ]
Zhu, Yichun [2 ]
Shi, Lin [2 ]
Wang, Xiangdong [1 ]
机构
[1] Wenzhou Med Univ, Hosp 1, Dept Resp Med, Wenzhou, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai Inst Clin Bioinformat, Ctr Clin Bioinformat, Shanghai 200433, Peoples R China
关键词
Precision medicine; Clinical bioinformatics; Biomarkers; Gene sequencing; Regulation; OBSTRUCTIVE PULMONARY-DISEASE; BACTERIAL TRANSLOCATION; ACUTE EXACERBATION; BIOMARKERS;
D O I
10.1007/s10555-015-9555-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The precision medicine as a new emerging area and therapeutic strategy has occurred and was practiced in the individual and brought unexpected successes, and gained high attentions from professional and social aspects as a new path to improve the treatment and prognosis of patients. There will be a number of new components to appear or be discovered, of which clinical bioinformatics integrates clinical phenotypes and informatics with bioinformatics, computational science, mathematics, and systems biology. In addition to those tools, precision medicine calls more accurate and repeatable methodologies for the identification and validation of gene discovery. Precision medicine will bring more new therapeutic strategies, drug discovery and development, and gene-oriented treatment. There is an urgent need to identify and validate disease-specific, mechanism-based, or epigenetics-dependent biomarkers to monitor precision medicine, and develop "precision" regulations to guard the application of precision medicine.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 18 条
[1]
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile [J].
Buffie, Charlie G. ;
Bucci, Vanni ;
Stein, Richard R. ;
McKenney, Peter T. ;
Ling, Lilan ;
Gobourne, Asia ;
No, Daniel ;
Liu, Hui ;
Kinnebrew, Melissa ;
Viale, Agnes ;
Littmann, Eric ;
van den Brink, Marcel R. M. ;
Jenq, Robert R. ;
Taur, Ying ;
Sander, Chris ;
Cross, Justin R. ;
Toussaint, Nora C. ;
Xavier, Joao B. ;
Pamer, Eric G. .
NATURE, 2015, 517 (7533) :205-U207
[2]
Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study [J].
Chen, Hong ;
Song, Zhenju ;
Qian, Mengjia ;
Bai, Chunxue ;
Wang, Xiangdong .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (06) :1286-1297
[3]
Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation [J].
Chen, Hong ;
Wang, Yaoli ;
Bai, Chunxue ;
Wang, Xiangdong .
JOURNAL OF PROTEOMICS, 2012, 75 (10) :2835-2843
[4]
A New Initiative on Precision Medicine [J].
Collins, Francis S. ;
Varmus, Harold .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09) :793-795
[5]
Expanding the computational toolbox for mining cancer genomes [J].
Ding, Li ;
Wendl, Michael C. ;
McMichael, Joshua F. ;
Raphael, Benjamin J. .
NATURE REVIEWS GENETICS, 2014, 15 (08) :556-570
[6]
Precision medicine: an approach to R&D for delivering superior medicines to patients [J].
Dolsten, Mikael ;
Sogaard, Morten .
CLINICAL AND TRANSLATIONAL MEDICINE, 2012, 1
[7]
Handelsman J., 2015, PRECISION MED IMPROV
[8]
Klauschen Frederick, 2014, Oncoscience, V1, P504
[9]
Cutting the Gordian Helix - Regulating Genomic Testing in the Era of Precision Medicine [J].
Lander, Eric S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13) :1185-1186
[10]
Preparing for Precision Medicine [J].
Mirnezami, Reza ;
Nicholson, Jeremy ;
Darzi, Ara .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) :489-491